Dosage Optimization of Digoxin in Older Patients with Heart Failure and Chronic Kidney Disease: A Population Pharmacokinetic Analysis

被引:0
作者
Zhong-Qiu Lin
Ling Guo
Li-Min Zhang
Jie-Jiu Lu
Xia Jiang
机构
[1] The First Affiliated Hospital of Guangxi Medical University,Department of Pharmacy
来源
Drugs & Aging | 2023年 / 40卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:539 / 549
页数:10
相关论文
共 167 条
  • [1] Ziff OJ(2015)Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data BMJ 351 98-102
  • [2] Lane DA(2003)Digoxin in heart failure and cardiac arrhythmias Med J Aust 179 2195-2203
  • [3] Samra M(2020)Digoxin: pharmacology and toxicology—a review Environ Toxicol Pharmacol 79 3-15
  • [4] Griffith M(2004)Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial J Am Soc Nephrol 15 815-822
  • [5] Kirchhof P(2019)Prevalence and disease burden of chronic kidney disease Adv Exp Med Biol 1165 124-129
  • [6] Lip GY(2012)Prevalence of chronic kidney disease in China: a cross-sectional survey Lancet 379 2683-137
  • [7] Campbell TJ(2021)Association of digoxin with mortality in patients with advanced chronic kidney disease: a population-based cohort study PLoS One 16 136-439
  • [8] Macdonald PS(2019)Drug–drug interactions of p-gp substrates unrelated to cyp metabolism Curr Drug Metab 20 433-404
  • [9] Patocka J(2015)Drugs and the kidney S Afr Med J 105 394-1074
  • [10] Nepovimova E(2022)The importance of free digoxin serum levels after digoxin poisoning Clin Toxicol (Phila) 60 1063-989